Illustration by tuput
English
WHO's Global Tuberculosis Report 2026, released on 12 November 2026, lists India among the high-burden countries that cut TB deaths by at least 35 per cent from the 2015 level. The health ministry puts the fall in India's death rate at 38 per cent and treatment success for drug-susceptible TB at 94 per cent.
India reached the first mortality milestone of the World Health Organization’s End TB Strategy in 2025, according to WHO’s Global Tuberculosis Report 2026, released on 12 November 2026. The milestone is a cut of at least 35 per cent in the number of TB deaths compared with 2015. WHO’s report pages list India among four high-burden countries outside the African and European regions that have reached it, and say India and China did so in 2025. The Union health ministry said the same day that India’s estimated TB mortality rate fell 38 per cent, from 28 deaths per lakh (100,000) people in 2015 to 18 in 2025, against a global decline of 35 per cent.
WHO built the 2026 edition on data from 187 countries and areas, which hold more than 99 per cent of the world’s people and TB cases. Globally, WHO says, the same 35 per cent milestone was reached in 2025, five years later than the End TB Strategy planned. This article separates what WHO’s own pages say about India from what the ministry added, because the two use different measures.
What WHO’s pages say about India’s deaths
WHO’s mortality page puts India’s share of global TB deaths in 2025 at 23 per cent, the largest of any country. It also records that the milestone is defined on the number of deaths, and that 89 countries had reached a net fall of at least 35 per cent by 2025. Four of the 30 high-burden countries outside the African and European regions are among them: Bangladesh, China, India and Viet Nam.
For India, WHO says it updated its mortality estimates for 2023 to 2025 with cause-of-death data from the Sample Registration System (a source of vital registration data in India, run by the Registrar General), covering 2022 to 2024, plus programme data for 2025. The technical appendix says the new data lowered WHO’s earlier estimates of TB deaths in India by about 8,000 for 2023 and about 20,000 for 2024.
What the health ministry added
The ministry’s statement, carried by DD India, PTI and All India Radio, puts the fall in India’s estimated TB mortality rate at 38 per cent, from 28 to 18 deaths per lakh people. It reports 94 per cent treatment success among patients with drug-susceptible TB and says 96 per cent of the funding the programme needs comes from domestic sources. The PIB release of 13 November describes the 38 per cent as India’s highest-ever reduction. It also quotes a post from WHO’s South-East Asia regional office: “India is making a significant contribution to the progress in reducing tuberculosis mortality in the WHO South-East Asia Region.”
Two details help in reading the 38 per cent. The 28 and 18 are rounded rates, and The Policy Edge notes they do not reproduce 38 exactly (by tuput’s arithmetic, a fall from 28 to 18 is about 36 per cent). It adds that a fall in the rate and a fall in the number of deaths should not be treated as interchangeable. The global 35 per cent is a fall in the number of deaths, from about 1.74 million in 2015 to 1.13 million in 2025, according to Health Policy Watch. None of the WHO pages opened for this article states the 94 per cent, and the ministry gives no cohort year for it. For comparison, WHO reports a global treatment success rate of 90 per cent for people treated for drug-susceptible TB in 2024, up from 81 per cent in 2016.
The screening drive behind the figures
The ministry gives programme totals for the TB Mukt Bharat Abhiyaan (the TB-free India campaign) from 7 December 2024 to 8 November 2026:
- More than 25 crore (250 million) people brought within the reach of screening.
- Over 11 crore (110 million) chest X-rays.
- More than 3 crore (30 million) rapid molecular tests.
- 48.64 lakh (4.86 million) TB cases identified, of which 14.97 lakh (1.5 million) had no symptoms. That is about 31 per cent, by tuput’s arithmetic.
The first intensified 100-day campaign began on 7 December 2024 in 347 high-priority districts in 33 states and Union territories and was later extended nationwide. A second began on 24 March 2026 and targeted 1.58 lakh high-risk villages and wards, congregate settings and vulnerable groups. The ministry also says 67,933 panchayats (village councils, explained in tuput’s piece on how panchayats and municipalities work) were declared TB-free in 2025. It names AI-read portable X-rays, rapid molecular tests, the Ni-kshay patient-tracking platform, nutrition support under the Ni-kshay Poshan Yojana and volunteer support through Ni-kshay Mitra among the tools. A Delhi slum-screening study shows how one AI X-ray programme worked in practice.
The Policy Edge points out that these totals describe reported programme activity and case-finding. They are not WHO estimates of how many people developed TB.
Where the money came from
WHO’s financing page says total TB funding in low- and middle-income countries was US$ 6.6 billion in 2025, up US$ 0.55 billion on 2024, “mainly attributable” to higher domestic funding in India, Indonesia and the Russian Federation. WHO’s news release says domestic funding rose 14 per cent to US$ 5.6 billion, partly offsetting a fall in international financing. Among 15 countries receiving US government bilateral funding and Global Fund grants, WHO names India as the exception to heavy reliance on Global Fund money. Health Policy Watch reports that the biggest increases in domestic funding were in India and Indonesia.
The global picture
WHO estimates 10.6 million people developed TB in 2025 and about 1.1 million died of it. The global incidence rate (new cases per 100,000 people) is down 14 per cent since 2015, against a 50 per cent milestone for 2025. India accounts for about a quarter of the world’s cases, WHO’s slide set says. Katherine Floyd of WHO told a briefing, as reported by Health Policy Watch, that most indicators “moved slowly in the right direction or were relatively stable” between 2024 and 2025. WHO’s Director-General Tedros Adhanom Ghebreyesus called the continued fall in cases and deaths “very encouraging.”
What WHO has left under review
WHO has not published India’s TB incidence estimates for 2010 to 2025. The slide set and report pages say they are under review, and PTI reports that the India country profile has also been withheld. The ministry says the ICMR-National Institute for Research in Tuberculosis ran a nationally representative prevalence survey in 2025, that its findings are with WHO in technical discussions, and that WHO is expected to publish an updated profile afterwards. South First reports that India’s district sentinel surveillance system covers 300 clusters in 50 districts, that its first round finished in 2025, and that updated incidence estimates are expected in early 2027.
The second End TB milestone, a 75 per cent fall in deaths by 2025, was close to being reached in seven high-burden countries, WHO says, and India is not among the seven it names. On drug-resistant TB, WHO estimates 370,000 people developed rifampicin-resistant TB worldwide in 2025 and 42 per cent received treatment. China, India, the Philippines and the Russian Federation together account for more than half of those cases, though WHO marks India’s drug-resistance trend estimates as under review too. Worldwide, use of the six-month treatment regimen for drug-resistant TB rose from 18 per cent in 2024 to 42 per cent in 2025.
Sources & further reading
- WHO: Global tuberculosis report 2026, report landing page (12 November 2026)
- WHO news release: Amid challenges, countries increase domestic investment to protect progress against tuberculosis (12 November 2026)
- WHO Global tuberculosis report 2026: 1.2 TB mortality
- WHO Global tuberculosis report 2026: 1.1 TB incidence
- WHO Global tuberculosis report 2026: 1.3 Drug-resistant TB
- WHO Global tuberculosis report 2026: 2.3 TB treatment coverage and outcomes
- WHO Global tuberculosis report 2026: 4.1 Financing for TB prevention, diagnostic and treatment services
- WHO: Global tuberculosis report 2026, technical appendix on disease burden estimates (PDF)
- WHO: Global TB report 2026 slide set (PDF)
- PIB, Ministry of Health and Family Welfare: Union Health Minister highlights India's progress in reducing TB mortality (13 November 2026)
- DD India, carrying the PIB text: India records 38% decline in TB mortality, 94% treatment success rate (12 November 2026)
- News On AIR (All India Radio): India achieves significant milestone in its fight against TB (13 November 2026)
- Siasat, carrying a PTI report: India's TB deaths drop 38 per cent since 2015 (13 November 2026)
- The Policy Edge: India's TB death rate falls, but the country still accounts for 23% of global TB deaths (13 November 2026)
- Health Policy Watch: Global tuberculosis burden declining, but five years behind schedule (13 November 2026)
- South First: India accounts for one in four global TB cases, reports 38% fall in deaths (14 November 2026)
Researched and written with the help of AI tools and edited for accuracy. Provided for general information and discussion only, not professional advice. See our editorial standards and disclaimer. Spotted an error? Tell us.
Enjoyed this? Get the next one.
One good read at a time, straight to your inbox. No spam, unsubscribe anytime.